BACKGROUND: The purpose of this study was to determine patient-specific risk factors and clinical intervention rates for abnormal postoperative Chem-7 panels in shoulder arthroplasty patients. METHODS: Retrospectively, all primary anatomic total (aTSA) and reverse shoulder (RTSA) arthroplasties (between 2007-2013) performed at a single institution were identified. All patients underwent routine preoperative and postoperative day one (POD1) chemistry panels. Each clinically significant component of the Chem-7 panel was independently evaluated using a multivariate analysis to identify risk factors for abnormal results. Associated clinical intervention rates were also calculated. RESULTS: Data from 1,012 patients (248 RTSA; 764 aTSA) was analyzed. 5.4% of patients had at least one preoperative abnormal chemistry result. On multivariate analysis, patients with abnormal preoperative Chem-7 labs and a history of renal disease had significantly increased risk for abnormal POD1 labs (P<0.001). Although 25.6% (259/1,012) of patients had at least one abnormal POD1 lab result, the total postoperative clinical intervention rate was 15.1% (39/259). CONCLUSION: Renal disease and a preoperative abnormal chemistry result are important risk factors for abnormal postoperative Chem-7. Optimizing renal status and correcting abnormal blood chemistry results preoperatively may reduce the incidence of abnormal postoperative chemistry results.
BACKGROUND: The purpose of this study was to determine patient-specific risk factors and clinical intervention rates for abnormal postoperative Chem-7 panels in shoulder arthroplasty patients. METHODS: Retrospectively, all primary anatomic total (aTSA) and reverse shoulder (RTSA) arthroplasties (between 2007-2013) performed at a single institution were identified. All patients underwent routine preoperative and postoperative day one (POD1) chemistry panels. Each clinically significant component of the Chem-7 panel was independently evaluated using a multivariate analysis to identify risk factors for abnormal results. Associated clinical intervention rates were also calculated. RESULTS: Data from 1,012 patients (248 RTSA; 764 aTSA) was analyzed. 5.4% of patients had at least one preoperative abnormal chemistry result. On multivariate analysis, patients with abnormal preoperative Chem-7 labs and a history of renal disease had significantly increased risk for abnormal POD1 labs (P<0.001). Although 25.6% (259/1,012) of patients had at least one abnormal POD1 lab result, the total postoperative clinical intervention rate was 15.1% (39/259). CONCLUSION: Renal disease and a preoperative abnormal chemistry result are important risk factors for abnormal postoperative Chem-7. Optimizing renal status and correcting abnormal blood chemistry results preoperatively may reduce the incidence of abnormal postoperative chemistry results.
Authors: David R Thomas; Syed H Tariq; Sohail Makhdomm; Rami Haddad; Asif Moinuddin Journal: J Am Med Dir Assoc Date: 2004 Mar-Apr Impact factor: 4.669
Authors: Chris A Anthony; Robert W Westermann; Yubo Gao; Andrew J Pugely; Brian R Wolf; Carolyn M Hettrich Journal: Clin Orthop Relat Res Date: 2014-12-19 Impact factor: 4.176
Authors: Alana M Murphy; Elena Tunitsky-Bitton; Ryan M Krlin; Matthew D Barber; Howard B Goldman Journal: Am J Obstet Gynecol Date: 2013-06-13 Impact factor: 8.661
Authors: Brian R Waterman; John C Dunn; Julia Bader; Luis Urrea; Andrew J Schoenfeld; Philip J Belmont Journal: J Shoulder Elbow Surg Date: 2014-08-29 Impact factor: 3.019